{Reference Type}: Journal Article
{Title}: Therapeutic cysteine protease inhibitors: a patent review (2018-present).
{Author}: Barchielli G;Capperucci A;Tanini D;
{Journal}: Expert Opin Ther Pat
{Volume}: 34
{Issue}: 1
{Year}: 2024 Jan-Feb 14
{Factor}: 6.714
{DOI}: 10.1080/13543776.2024.2327299
{Abstract}: <B>UNASSIGNED: </B>Cysteine proteases are involved in a broad range of biological functions, ranging from extracellular matrix turnover to immunity. Playing an important role in the onset and progression of several diseases, including cancer, immune-related and neurodegenerative disease, viral and parasitic infections, cysteine proteases represent an attractive drug target for the development of therapeutic tools.<BR><B>UNASSIGNED: </B>Recent scientific and patent literature focusing on the design and study of cysteine protease inhibitors with potential therapeutic application has been reviewed.<BR><B>UNASSIGNED: </B>The discovery of a number of effective structurally diverse cysteine protease inhibitors opened up new challenges and opportunities for the development of therapeutic tools. Mechanistic studies and the availability of X-ray crystal structures of some proteases, alone and in complex with inhibitors, provide crucial information for the rational design and development of efficient and selective cysteine protease inhibitors as preclinical candidates for the treatment of different diseases.